N-(1-(2-FLUOROETHYL)IMIDAZOLIDIN-2-YLIDENE)NITRAMIDE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	OASYSNTUYUMIPG-UHFFFAOYSA-N
Smiles	[O-][N+](=O)\N=C\1/NCCN1CCF
InChI	InChI=1S/C5H9FN4O2/c6-1-3-9-4-2-7-5(9)8-10(11)12/h1-4H2,(H,7,8)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C5H9FN4O2
Molecular Weight	176.15
AlogP	2.06
Hydrogen Bond Acceptor	5.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	3.0
Polar Surface Area	73.45
Molecular species	NEUTRAL
Aromatic Rings	0.0
Heavy Atoms	12.0

Assay Description	Organism	Bioactivity
Insecticidal activity against adult Aphis gossypii (cotton aphid) in cucumber cotyledons assessed as mortality at 500 ppm treated for 5 secs before adult infestation measured after 72 hr	Aphis gossypii	47.0 %
Displacement of [3H]IMI from nicotinic acetylcholine receptor in Drosophila melanogaster brain at Ki concentration	Drosophila melanogaster	44.0 %
Displacement of [3H]IMI from nicotinic acetylcholine receptor in Drosophila melanogaster brain	Drosophila melanogaster	100000.0 nM
Insecticidal activity against Aulacophora femoralis (cucurbit leaf beetle) at 500 ppm	Aulacophora	0.0 %
Insecticidal activity against Spodoptera litura at 500 ppm	Spodoptera litura	0.0 %
Insecticidal activity against Myzus persicae (green peach aphid) at 500 ppm	Myzus persicae	60.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2229406
PubChem	76315074

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).